99Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and graves’ ophthalmopathy (Review) | |
Wu Q.; Ni Y.; Yang Q.; Sun H. | |
刊名 | Biomedical Reports
![]() |
2016 | |
卷号 | 4期号:4页码:400-402 |
关键词 | Choroidal neovascularization Graves’ ophthalmopath Rheumatoid arthritis Technetium 99 conjugated with methylene diphosphonate Therapy |
DOI | 10.3892/br.2016.609 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4711687 |
专题 | 山东大学 |
作者单位 | 1.Departments of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China 2.[ N |
推荐引用方式 GB/T 7714 | Wu Q.,Ni Y.,Yang Q.,et al. 99Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and graves’ ophthalmopathy (Review)[J]. Biomedical Reports,2016,4(4):400-402. |
APA | Wu Q.,Ni Y.,Yang Q.,&Sun H..(2016).99Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and graves’ ophthalmopathy (Review).Biomedical Reports,4(4),400-402. |
MLA | Wu Q.,et al."99Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and graves’ ophthalmopathy (Review)".Biomedical Reports 4.4(2016):400-402. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论